Exploring mechanisms of protein influence on calcium oxalate kidney stone formation.


Journal

Urolithiasis
ISSN: 2194-7236
Titre abrégé: Urolithiasis
Pays: Germany
ID NLM: 101602699

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 11 11 2020
accepted: 23 01 2021
pubmed: 16 2 2021
medline: 15 12 2021
entrez: 15 2 2021
Statut: ppublish

Résumé

Calcium oxalate monohydrate (COM) crystals are the primary constituent of most kidney stones, but urine proteins in stone matrix are believed to be critical elements for stone formation from these crystals. Recent data have shown that hundreds of proteins appear in the stone matrix with no explanation for inclusion of so many proteins. We have proposed a stone formation model with protein stimulated COM aggregation based on polyanion-polycation aggregation, which is supported by finding that matrix is highly enriched in strongly anionic and strongly cationic proteins. Many other proteins may be drawn to such aggregates due to their limited solubility in water or charge effects. Finding similar protein enrichment in both polyarginine (pR) induced aggregates of urine proteins and COM stone matrix would support this hypothesis. Purified proteins (PP) were obtained from random urine samples of six healthy adults by ultradiafiltration. Protein aggregation was induced by adding pR to PP solutions at two concentrations; 0.25 and 0.5 µg pR/µg of PP. Samples of each fraction and the original PP mixture were lyophilized and analyzed by tandem mass spectrometry. Aggregates induced by pR addition to PP samples collected a protein mixture that mimicked the protein distribution observed in COM matrix, supporting our hypothesis. The apparently discordant behavior of certain abundant anionic proteins preferentially joining the pR aggregate, when they had demonstrated reduced abundance in COM stone matrix, suggests that this model was overdriven to aggregate. The reversal of aggregate preference of albumin at low pR addition supports this interpretation.

Identifiants

pubmed: 33587148
doi: 10.1007/s00240-021-01247-5
pii: 10.1007/s00240-021-01247-5
pmc: PMC8316271
mid: NIHMS1691887
doi:

Substances chimiques

Proteins 0
Calcium Oxalate 2612HC57YE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

281-290

Subventions

Organisme : NIDDK NIH HHS
ID : R25 DK098104
Pays : United States
Organisme : CSRD VA
ID : I01 CX001491
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK082550
Pays : United States
Organisme : NIDDK NIH HHS
ID : R25DK098104
Pays : United States
Organisme : NIH HHS
ID : DK 82550
Pays : United States
Organisme : U.S. Department of Veterans Affairs
ID : CX-001491-01A2

Informations de copyright

© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Références

Proteomics. 2011 Mar;11(6):1058-63
pubmed: 21365761
Urolithiasis. 2019 Dec;47(6):521-532
pubmed: 30993355
Urolithiasis. 2019 Jun;47(3):225-234
pubmed: 29947995
Clin J Am Soc Nephrol. 2011 Aug;6(8):2083-92
pubmed: 21825103
Urolithiasis. 2017 Feb;45(1):57-74
pubmed: 27913854
Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):426-30
pubmed: 1729712
J Urol. 2011 Apr;185(4):1304-11
pubmed: 21334658
J Urol. 1956 Sep;76(3):213-27
pubmed: 13368269
Proteome Sci. 2016 Feb 27;14:4
pubmed: 26924944
Am J Physiol Renal Physiol. 2008 Oct;295(4):F1254-8
pubmed: 18701630
Bioinformatics. 2009 Jun 1;25(11):1422-3
pubmed: 19304878
Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):267-72
pubmed: 15625112
J Urol. 1989 Dec;142(6):1516-21
pubmed: 2585627
Front Biosci. 2004 May 01;9:1450-82
pubmed: 14977559
Urolithiasis. 2017 Aug;45(4):337-346
pubmed: 28314883
Eur Urol. 2012 Jul;62(1):160-5
pubmed: 22498635
Urol Res. 2005 Jun;33(3):206-12
pubmed: 15864572
Urology. 2010 Oct;76(4):1017.e13-20
pubmed: 20709378
Carbohydr Res. 2007 Jan 15;342(1):79-86
pubmed: 17145044
Genome Biol. 2006;7(9):R80
pubmed: 16948836
Urolithiasis. 2015 Jan;43 Suppl 1:19-32
pubmed: 25108546

Auteurs

Garrett K Berger (GK)

Division of Nephrology, Department of Medicine, Medical College of Wisconsin, 9200 W Wisconsin Avenue, Milwaukee, WI, 53295, USA.

Jessica Eisenhauer (J)

Division of Nephrology, Department of Medicine, Medical College of Wisconsin, 9200 W Wisconsin Avenue, Milwaukee, WI, 53295, USA.

Andrew Vallejos (A)

Department of Biomedical Engineering, Max McGee National Research Center, Cardiovascular Center, Center for Advancing Population Science, Medical College of Wisconsin and Marquette University, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA.
Clinical Science and Translational Institute, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA.

Brian Hoffmann (B)

Clinical Science and Translational Institute, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA.
Department of Physiology, Max McGee National Research Center, Cardiovascular Center, Center for Advancing Population Science, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA.
The Jackson Laboratory, Mass Spectrometry and Protein Chemistry, Protein Sciences, Bar Harbor, ME, 04609, USA.

Jeffrey A Wesson (JA)

Division of Nephrology, Department of Medicine, Medical College of Wisconsin, 9200 W Wisconsin Avenue, Milwaukee, WI, 53295, USA. jwesson@mcw.edu.
Consultant Care Division/Nephrology Section, Clement J. Zablocki Department of Veterans Affairs Medical Center, 5000 W National Avenue (111K), Milwaukee, WI, 53295, USA. jwesson@mcw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH